Hympavzi (marstacimab-hncq) Coverage Criteria
Customize your policy alerts
Sign up for all UnitedHealthcare policy alerts
Know when UnitedHealthcare releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and reauthorization for Hympavzi used for routine prophylaxis to prevent or reduce bleeding episodes in members aged 6 years and older with hemophilia A or hemophilia B under UnitedHealthcare commercial pharmacy coverage.
The policy expanded coverage criteria to include hemophilia A with or without factor VIII inhibitors and hemophilia B with or without factor IX inhibitors.
The policy updated the minimum age requirement to patients 6 years of age and older.
The indications were updated to include prevention or reduction in the frequency of bleeding episodes.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.